Induction of cell cycle arrest and apoptosis by a combined treatment with 13-cis-retinoic acid, interferon-α2a, and α-tocopherol in squamous cell carcinoma of the head and neck

Head and Neck

Volumn 29, Issue 4, 2007, Pages 351-361

  Zhang, Xin ^a   Chen, Zhuo ^a   Khuri, Fadlo R ^a   Shin, Dong M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

tocopherol; Interferon 2a; Retinoic acid; Squamous cell carcinoma of the head and neck

Indexed keywords

ALPHA TOCOPHEROL; ALPHA2A INTERFERON; ISOTRETINOIN; LIPOCORTIN 5;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL GROWTH; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ALPHA-TOCOPHEROL; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOPREVENTION; DRUG THERAPY, COMBINATION; HUMANS; INTERFERON ALFA-2A; ISOTRETINOIN; OTORHINOLARYNGOLOGIC NEOPLASMS;

EID: 34247245665     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20525     Document Type: Article

References (50)

1. Hong WK, Endicott J, Itri LM, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986;315:1501-1505.
2. Lotan R. Retinoids in cancer chemoprevention. FASEB J 1996;10:1031-1039.
3. Borden EC. Interferons: expending therapeutic roles. N Engl J Med 1992;149:1491-1493.
4. Ohashi M, Yoshida K, Kushida M, et al. Adenovirus-mediated interferon-α gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancer. Br J Cancer 2005;93:441-449.
5. Indraccolo S, Tisato V, Tosello V, et al. Interferon-α gene therapy by lentiviral vectors contrasts ovarian cancer growth through angiogenesis inhibition. Hum Gene Ther 2005;16:957-970.
6. Lancillotti F, Giandomenico V, Affabris E, Fiorucci G, Romeo G, Rossi GB. Interferon α-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells. Cancer Res 1995;55:3158-3164.
7. Zou C, Ramakumar S, Qian L, et al. Effect of retinoic acid and interferon α-2a on transitional cell carcinoma of bladder. J Urol 2005;173:247-251.
8. Lingen MW, Polverini PJ, Bouck NP. Retinoic acid and interferon a act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma. Cancer Res 1998;58:5551-5558.
9. Lippman SM, Parkinson DR, Itri LM, et al. 13-cis-retinoic acid and interferon α-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 1992;84:235-241.
10. Lippman SM, Glisson BS, Kavanagh JJ, et al. Retinoic acid and interferon combination studies in human cancer. Eur J Cancer 1993;29(Suppl. 5):S9-S13.
11. Dimery IW, Hong WK, Lee JJ, et al. Phase I trial of α-tocopherol effects on13-cis-retinoic acid toxicity. Ann Oncol 1997;8:85-89.
12. Shin DM, Mao L, Papadimitrakopoulou VM, et al. Biochemopreventive therapy for patients with premalignant lesions of head and neck and p53 gene expression. J Natl Cancer Inst 2000;92:69-73.
13. Papadimitrakopoulou VM, Liu DD, Mao L, et al. Biologic correlates of a biochemoprevention trail in advanced upper aerodigestive tract premalignant lesions. Cancer Epidemiol Miomarkers Prev 2002;11:1605-1610.
14. Shin DM, Khuri FR, Murphy B, et al. Combined interferon-α, 13-cis-retinoic acid, and α-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial. J Clin Oncol 2001;19:3010-3017.
15. Seixas-Silva JA Jr, Richards T, Khuri FR, et al. Phase 2 bioadjuvant study of interferon α-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-up. Arch Otolaryngol Head Neck Surg 2005;131:304-307.
16. Chambon P. The molecular and genetic dissection of the retinoid signaling pathway. Recent Prog Horm Res 1995;50:317-332.
17. Gudas LJ, Sporn MB, Roberts AB. Cellular biology and biochemistry of the retinoids. In: Sporn MB, Roberts AB, Goodman DS, editors. The retinoids: biology, chemistry and medicine, 2nd ed. New York: Raven Press; 1994. pp 443-520.
18. Petkovich M. Regulation of gene expression by vitamin A: the role of nuclear retinoic acid receptors. Annu Rev Nutr 1992;12:443-471.
19. Darnell JE, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264:1415-1421.
20. Tanaka N, Kawakami T, Taniguchi T. Recognition DNA sequences of interferon regulator 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol Cell Biol 1993;13:4531-4538.
21. Miyamoto M, Fujita T, Kimura Y, et al. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements. Cell 1988;54:903-913.
22. Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990;82:1107-1112.
23. Pinto H, Li Y, Loprinzi C, et al. Phase III trail of low dose 13-cis-retinoic acid for prevention of second primary cancers in stage I-II head and neck cancer - an Eastern Cooperative Oncology Group Study. Proc Am Soc Clin Oncol 2001;20:222a. (abstract No. 886).
24. Khuri F, Lee JJ, Lippman SM, et al. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst 2006;98:441-450.
25. Sacks PG, Oke V, Amos B, Vasey T, Lotan R. Modulation of growth, differentiation and glycoprotein synthesis by β-all-trans retinoic acid in a multicellular tumor spheroid model for squamous carcinoma of the head and neck. Int J Cancer 1989;44:926-933.
26. Sacks PG, Oke V, Vasey T, Lotan R. Retinoic acid inhibition of a head and neck multicellular tumor spheroid model. Head Neck 1989;11:219-225.
27. Sacks PG, Racz T, Schantz SP, Rosenblum MG. Growth inhibition by interferon p and 7 of MDA 886Ln monolayer cells and multicellular tumor spheroids. A differentiation therapy model for squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1994;120:1267-1272.
28. Lippman SM, Benner SE, Hong WK. Cancer chemoprevention. J Clin Oncol 1994;12:851-873.
29. Neuzil J, Zhao M, Ostermann G, et al. α-Tocopherol succinate, an agent with in vivo anti-tumor activity, induces apoptosis by causing lysosomal instability. Biochem J 2002;362:709-715.
30. Ni J, Cheng M, Zhang Y, Li R, Huang J, Yeh S. Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery. Biochem Biophys Res Commun 2003;300:357-363.
31. Rose AT, McFadden DW. α-Tocopherol succinate inhibits growth of gastric cancer cells in vitro. J Surg Res 2001;95:19-22.
32. Formelli F, Cavadini E, Mascheroni L, Belli F, Cascinelli N. Pharmacokinetics and effects on plasma retinol concentrations of 13-cis-retinoic acid in melanoma patients. Br J Cancer 1997;76:1655-1660.
33. Wills RJ. Clinical pharmacokinetics of interferons. Clin Pharmacokinet 1990;19:390-399.
34. Dimitrov NV, Meyer-Leece C, McMillan J, Gilliland D, Perloff M, Malone W. Plasma α-tocopherol concentrations after supplementation with water- and fat-soluble vitamin E. Am J Clin Nutr 1996;64:329-335.
35. Giannini F, Maestro R, Vukosavljevic T, Pomponi F, Boiocchi M. All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use. Int J Cancer 1997;70:194-200.
36. Fujimura S, Suzumiya J, Anzai K, et al. Retinoic acids induce growth inhibition and apoptosis in adult T-cell leukemia (ATL) cell lines. Leuk Res 1998;22:611-618.
37. Grebenova D, Kuzelova K, Fuchs O, et al. Interferon-α suppresses proliferation of chronic myelogenous leukemia cells K562 by extending cell cycle S-phase without inducing apoptosis. Blood Cells Mol Dis 2004;32:262-269.
38. Sangfelt O, Erickson S, Castro J, et al. Molecular mechanisms underlying interferon-α-induced G0/G1 arrest. CKI-mediated regulation of G1 Cdk-complexs and activation of pocket proteins. Oncogene 1999;18:2798-2810.
39. Venkateswaran V, Fleshner NE, Klotz LH. Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines. J Urol 2002;168:1578-1582.
40. Porta C, Hadj-Slimane R, Nejmeddine M, et al. Interferon α and γ induce p53-dependent and p53-independent apoptosis respectively. Oncogene 2005;24:605-615.
41. Neuzil J, Kagedal K, Andera L, Weber C, Brunk UT. Vitamin E analogs: a new class of multiple action agents with anti-neoplastic and anti-atherogenic activity. Apoptosis 2002;7:179-187.
42. Sun SY, Hail N Jr, Lotan R. Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst 2004;96:662-672.
43. Hajra KM, Liu JR. Apoptosome dysfunction in human cancer. Apoptosis 2004;9:691-704.
44. Rigobello MP, Scutari G, Friso A, Barzon E, Artusi S, Bindoli A. Mitochondrial permeability transition and release of cytochrome c induced by retinoic acids. Biochem Pharmacol 1999;58:665-670.
45. Li C, Chi S, He N, et al. INFα induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signaling. Oncogene 2004;23:1608-1617.
46. Liedtke C, Groger N, Manns MP, Trautwein C. Interferon-α enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cells. J Hepatol 2006;44:342-349.
47. Shun MC, Yu W, Gapor A, et al. Pro-apoptotic mechanisms of action of a novel vitamin E analog (α-TEA) and a naturally occurring form of vitamin E (δ-tocotrienol) in MDA-MB-435 human breast cancer cells. Nutr Cancer 2004;48:95-105.
48. Tomasetti M, Rippo MR, Alleva R, et al. α-Tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells. Br J Cancer 2004;90:1644-1653.
49. Panaretakis T, Pokrovskaja K, Shoshan MC, Grander D. Interferon-α- induced apoptosis in U266 cells is associated with activation of the proapoptosis Bcl-2 family members Bak and Bax. Oncogene 2003;22:4543-4556.
50. Yu W, Sanders BG, Kline K. RRR-α-tocopherol succinate-induced apoptosis of human breast cancer cells involves Bax translocation to Mitochondria. Cancer Res 2003;63:2483-2491.